Dimerization of Amyloid Precursor Proteins and Alzheimer's Disease Mutants
Author Information
Author(s): Gorman Paul M, Kim Sanguk, Guo Meng, Melnyk Roman A, McLaurin Joanne, Fraser Paul E, Bowie James U, Chakrabartty Avijit
Primary Institution: University of Toronto
Hypothesis
FAD mutations in the APP-TM domain disrupt dimerization, leading to increased Aβ42/40 ratios.
Conclusion
The study shows that APP-TM dimerization is correlated with Aβ42/40 ratios and age of onset in Alzheimer's disease.
Supporting Evidence
- FAD mutations in APP-TM destabilize the dimer and increase monomer population.
- Dimerization constants correlate with Aβ42/Aβ40 ratios and mean age of disease onset.
- APP-TM peptides reduce Aβ production in HEK293 cells overexpressing FAD mutations.
Takeaway
This study found that the way a protein related to Alzheimer's disease sticks together can change when there are mutations, which might make the disease worse.
Methodology
The study used synthetic peptides and various biophysical techniques to analyze dimerization and its effects on Aβ production.
Limitations
The study primarily used in vitro models, which may not fully replicate in vivo conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website